Lv11
42 积分 2021-08-24 加入
Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
9小时前
已完结
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
1个月前
已完结
In Vitro Drug-Drug Interaction Evaluation of GalNAc Conjugated siRNAs Against CYP450 Enzymes and Transporters
1个月前
已完结
Chirality Dependent Potency Enhancement and Structural Impact of Glycol Nucleic Acid Modification on siRNA
1个月前
已完结
Immunogenicity Risk Assessment for Nucleic Acid Therapeutics: A Comprehensive Evaluation for ASO, siRNA, and Nonvaccine mRNA/LNP Therapies by the IQ Consortium
1个月前
已完结
Reversal of siRNA-mediated gene silencing in vivo
2个月前
已完结
Tolerable Levels of Nonclinical Vehicles and Formulations Used in Studies by Multiple Routes in Multiple Species With Notes on Methods to Improve Utility
2个月前
已完结
Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease
2个月前
已完结
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)
2个月前
已完结
Lepodisiran - A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
2个月前
已完结
皖公网安备34019202002308
